US gene therapy in crisis

Trends in Genetics

Volumn 16, Issue 6, 2000, Pages 272-275

  Zallen, Doris Teichler ^a  

^a VIRGINIA POLYTECHNIC INSTITUTE AND STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; DEATH; GENE THERAPY; GENETIC MANIPULATION; HUMAN; HUMAN EXPERIMENT; MALE; MEDICAL RESEARCH; PRIORITY JOURNAL; RECOMBINANT DNA TECHNOLOGY; REVIEW; UNITED STATES;

CLINICAL PROTOCOLS; GENE THERAPY; HEALTH POLICY; HUMANS; MALE; NATIONAL INSTITUTES OF HEALTH (U.S.); PROFESSIONAL STAFF COMMITTEES; UNITED STATES; UNITED STATES FOOD AND DRUG ADMINISTRATION;

EID: 0034212434     PISSN: 01689525     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0168-9525(00)02025-4     Document Type: Review

References (15)

1. Marshall, E. (1995) Gene therapy's growing pains. Science 269, 1050-1055
2. Weiss, R. and Nelson, D. (1999) Philadelphia Inquirer, 29 September, p. 1
3. Wade, N. (1999) The New York Times, 30 September p 22
4. Wright, S. (1994) Molecular Politics: Developing American and British Regulatory Policy for Genetic Engineering 1972-1982. University of Chicago Press
5. Diamond v. Chakrabarty (1980) US Reports 447, 303-322
6. National Institutes of Health. (1981) Report of the NIH Ad Hoc Committee on the UCLA Report Concerning Certain Research Activities of Dr. Martin J. Clin
7. Randall, C. et al. (1980) Letter from Three General Secretaries. In Splicing Life: A Report on the Social and Ethical Issues of Genetic Engineering with Human Beings pp. 95-96, US Government Printing Office
8. Brown, G.E., Jr (1981) The policymaking challenge of the bioengineering industry. Recombinant DNA Bull. 4, 121-123
9. 45 CFR (Code of Federal Regulations) Part 46 Protection of Research Subects. US Government Printing Office
10. Office of Recombinant DNA Activities (1997) Appendix M: The Points to Consider in the Design and Submission of Protocols for the Transfer of Recombinant DNA Molecules into One or More Human Subjects. US Department of Health and Human Services
11. Walters, L. and Palmer, J. (1997) The Ethics of Human Gene Therapy. Oxford University Press
12. Blaese, R.M. (1990) Treatment of severe combined immune deficiency (SCID) due to adenosine deaminase (ADA) deficiency with autologous lymphocytes transduced with the human ADA gene. Office of Recombinant DNA Activities, protocol 9007-002
13. Adams, C., (2000) Wall Street Journal, 10 January, section B, p 4
14. Paul, D. (1995) Controlling Human Heredity: 1865 to the Present. Humanities Press
15. Friend, T. (1999) USA Today 3 September, p. 1